NASDAQ:HQY HealthEquity (HQY) Stock Price, News & Analysis → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free HQY Stock Alerts $82.96 +1.52 (+1.87%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$81.60▼$83.7250-Day Range$69.74▼$83.5052-Week Range$48.86▼$84.13Volume542,154 shsAverage Volume596,275 shsMarket Capitalization$7.12 billionP/E Ratio244.00Dividend YieldN/APrice Target$87.38 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get HealthEquity alerts: Email Address HealthEquity MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside5.3% Upside$87.38 Price TargetShort InterestBearish3.46% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.09Based on 16 Articles This WeekInsider TradingSelling Shares$3.45 M Sold Last QuarterProj. Earnings Growth37.25%From $1.53 to $2.10 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.22 out of 5 starsMedical Sector727th out of 947 stocksBusiness Services, Not Elsewhere Classified Industry72nd out of 89 stocks 1.5 Analyst's Opinion Consensus RatingHealthEquity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $87.38, HealthEquity has a forecasted upside of 5.3% from its current price of $82.96.Amount of Analyst CoverageHealthEquity has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.46% of the outstanding shares of HealthEquity have been sold short.Short Interest Ratio / Days to CoverHealthEquity has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in HealthEquity has recently increased by 2.41%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldHealthEquity does not currently pay a dividend.Dividend GrowthHealthEquity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HQY. Previous Next 2.8 News and Social Media Coverage News SentimentHealthEquity has a news sentiment score of 1.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for HealthEquity this week, compared to 5 articles on an average week.Search InterestOnly 4 people have searched for HQY on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HealthEquity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,449,705.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of HealthEquity is held by insiders.Percentage Held by Institutions98.46% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for HealthEquity are expected to grow by 37.25% in the coming year, from $1.53 to $2.10 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of HealthEquity is 244.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 152.48.Price to Earnings Ratio vs. SectorThe P/E ratio of HealthEquity is 244.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 225.29.Price to Earnings Growth RatioHealthEquity has a PEG Ratio of 1.29. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHealthEquity has a P/B Ratio of 3.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingAI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit About HealthEquity Stock (NASDAQ:HQY)HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.Read More HQY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HQY Stock News HeadlinesMarch 18, 2024 | markets.businessinsider.comHere's what to expect from HealthEquity's earnings reportMarch 18, 2024 | msn.comHealthEquity Q4 2024 Earnings PreviewMarch 19, 2024 | Banyan Hill Publishing (Ad)AI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… March 18, 2024 | entrepreneur.comHQY Pre-Earnings Assessment: Should You Invest in HealthEquity?March 18, 2024 | benzinga.comEarnings Outlook For HealthEquityMarch 16, 2024 | americanbankingnews.comHealthEquity, Inc. (NASDAQ:HQY) to Post FY2024 Earnings of $1.62 Per Share, Zacks Research ForecastsMarch 15, 2024 | finance.yahoo.comShould You Be Confident in HealthEquity (HQY)?March 14, 2024 | finance.yahoo.comHealthEquity's (NASDAQ:HQY) investors will be pleased with their decent 48% return over the last yearMarch 19, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.March 13, 2024 | seekingalpha.comClover Health stock climbs as FY core earnings improve, eyes profitable adj. EBITDAMarch 12, 2024 | americanbankingnews.comHealthEquity (HQY) Scheduled to Post Quarterly Earnings on TuesdayMarch 11, 2024 | americanbankingnews.comHealthEquity, Inc. (NASDAQ:HQY) Given Average Rating of "Buy" by AnalystsMarch 5, 2024 | globenewswire.comHealthEquity Sets Date to Announce Fiscal Year End ResultsFebruary 24, 2024 | msn.comHealthEquity (HQY) Price Target Increased by 5.94% to 95.10February 23, 2024 | realmoney.thestreet.comHealthEquity price target raised by $13 at RBC Capital, here's whyFebruary 23, 2024 | finanznachrichten.deHealthEquity, Inc.: HealthEquity Reports Year-End Sales MetricsFebruary 21, 2024 | finance.yahoo.comHealthEquity Reports Year-End Sales MetricsFebruary 21, 2024 | globenewswire.comHealthEquity Reports Year-End Sales MetricsFebruary 17, 2024 | ca.finance.yahoo.comHQY Jun 2024 90.000 putFebruary 17, 2024 | ca.finance.yahoo.comHQY Mar 2024 80.000 putFebruary 14, 2024 | finance.yahoo.comHealthEquity, Inc. (NASDAQ:HQY) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?February 12, 2024 | finance.yahoo.comHere's Why You Should Add HealthEquity (HQY) to Your PortfolioFebruary 10, 2024 | finance.yahoo.comInsider Sell: EVP, GC & Corporate Secretary Delano Ladd Sells 2,499 Shares of HealthEquity ...February 9, 2024 | finance.yahoo.com3 Medical Services Stocks to Buy Amid Industry HeadwindsFebruary 1, 2024 | finance.yahoo.comIs HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?January 24, 2024 | finance.yahoo.comHealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?January 17, 2024 | finance.yahoo.comELV or HQY: Which Is the Better Value Stock Right Now?See More Headlines Receive HQY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/06/2021Today3/19/2024Next Earnings (Confirmed)3/19/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:HQY CUSIPN/A CIK1428336 Webwww.healthequity.com Phone(801) 727-1000Fax801-727-1005Employees3,208Year FoundedN/APrice Target and Rating Average Stock Price Target$87.38 High Stock Price Target$104.00 Low Stock Price Target$72.00 Potential Upside/Downside+5.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$0.34 Trailing P/E Ratio244.00 Forward P/E Ratio54.22 P/E Growth1.29Net Income$-26,140,000.00 Net Margins3.00% Pretax Margin4.67% Return on Equity5.89% Return on Assets3.72% Debt Debt-to-Equity Ratio0.44 Current Ratio4.93 Quick Ratio4.93 Sales & Book Value Annual Sales$861.75 million Price / Sales8.26 Cash Flow$2.74 per share Price / Cash Flow30.26 Book Value$22.40 per share Price / Book3.70Miscellaneous Outstanding Shares85,800,000Free Float83,484,000Market Cap$7.12 billion OptionableOptionable Beta0.53 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Jon Kessler (Age 56)President, CEO & Director Comp: $1.55MDr. Stephen D. Neeleman (Age 56)Founder & Vice Chairman Comp: $770.67kMr. Elimelech Rosner (Age 67)Executive VP & CTO Comp: $1.74MMr. James M. Lucania (Age 45)CFO & Executive VP Ms. Angelique Christine Hill (Age 55)Executive Vice President of Operations Mr. Richard PutnamVice President of Investor RelationsMr. Delano Ladd (Age 43)Executive VP, General Counsel & Secretary Comp: $319.48kMr. Steve LindsayExecutive Vice President of Sales & Relationship ManagementMr. Brad BennionSenior Vice President of Corporate DevelopmentMs. Tia PadiaExecutive VP & Chief Marketing OfficerMore ExecutivesKey CompetitorsApellis PharmaceuticalsNASDAQ:APLSThe Ensign GroupNASDAQ:ENSGDENTSPLY SIRONANASDAQ:XRAYShift4 PaymentsNYSE:FOURExelixisNASDAQ:EXELView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 104,084 shares on 3/11/2024Ownership: 10.046%Wellington Management Group LLPSold 18,703 shares on 3/5/2024Ownership: 0.778%Goldman Sachs Group Inc.Bought 223,428 shares on 3/1/2024Ownership: 1.317%Delano LaddSold 2,558 sharesTotal: $211,265.22 ($82.59/share)American International Group Inc.Sold 4,908 shares on 2/28/2024Ownership: 0.183%View All Insider TransactionsView All Institutional Transactions HQY Stock Analysis - Frequently Asked Questions Should I buy or sell HealthEquity stock right now? 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HQY shares. View HQY analyst ratings or view top-rated stocks. What is HealthEquity's stock price target for 2024? 8 brokers have issued 1 year target prices for HealthEquity's shares. Their HQY share price targets range from $72.00 to $104.00. On average, they anticipate the company's share price to reach $87.38 in the next twelve months. This suggests a possible upside of 5.3% from the stock's current price. View analysts price targets for HQY or view top-rated stocks among Wall Street analysts. How have HQY shares performed in 2024? HealthEquity's stock was trading at $66.30 at the beginning of 2024. Since then, HQY shares have increased by 25.1% and is now trading at $82.96. View the best growth stocks for 2024 here. When is HealthEquity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024. View our HQY earnings forecast. How can I listen to HealthEquity's earnings call? HealthEquity will be holding an earnings conference call on Tuesday, March 19th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-1837 with passcode "HEALTHEQUITY". How were HealthEquity's earnings last quarter? HealthEquity, Inc. (NASDAQ:HQY) posted its earnings results on Monday, December, 6th. The company reported $0.35 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.35. The firm had revenue of $180 million for the quarter, compared to the consensus estimate of $185.44 million. HealthEquity had a trailing twelve-month return on equity of 5.89% and a net margin of 3.00%. The business's revenue was up .3% on a year-over-year basis. During the same period in the previous year, the business posted $0.30 EPS. What ETFs hold HealthEquity's stock? ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), SPDR S&P Health Care Services ETF (XHS), Global X FinTech Thematic ETF (FINX), Motley Fool Small-Cap Growth ETF (TMFS), MFAM Small-Cap Growth ETF (MFMS), Nuveen Small Cap Select ETF (NSCS), Putnam Sustainable Future ETF (PFUT) and iShares U.S. Healthcare Providers ETF (IHF). What guidance has HealthEquity issued on next quarter's earnings? HealthEquity updated its FY 2025 earnings guidance on Wednesday, February, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. What is Jon Kessler's approval rating as HealthEquity's CEO? 359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend. What other stocks do shareholders of HealthEquity own? Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP). Who are HealthEquity's major shareholders? HealthEquity's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.05%), Vanguard Group Inc. (10.05%), Wasatch Advisors LP (7.97%), Clearbridge Investments LLC (2.75%), Brown Advisory Inc. (2.11%) and Mackenzie Financial Corp (2.11%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten. View institutional ownership trends. How do I buy shares of HealthEquity? Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HQY) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthEquity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.